Application 020701
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CRINONE | PROGESTERONE | GEL;VAGINAL | 4% | Yes | Yes |
| 002 | CRINONE | PROGESTERONE | GEL;VAGINAL | 8% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-6150 | Crinone | progesterone | Allergan, Inc. | NDA | Current |
| 0023-6151 | Crinone | progesterone | Allergan, Inc. | NDA | Current |
| 52544-255 | Crinone | progesterone | Actavis Pharma, Inc. | NDA | Current |
| 52544-256 | Crinone | progesterone | Actavis Pharma, Inc. | NDA | Current |
| 55056-0406 | Prochieve | progesterone | Columbia Laboratories | NDA | Current |
| 55056-0806 | Crinone | progesterone | Columbia Laboratories, Inc. | NDA | Current |
| 55056-0808 | Crinone | progesterone | Columbia Laboratories, Inc. | NDA | Current |
| 55056-0818 | Crinone | progesterone | Columbia Laboratories, Inc. | NDA | Current |
| 55056-1601 | Prochieve | progesterone | Columbia Laboratories | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 13242 | SUPPL | 2013-08-22 |
| 35168 | SUPPL | 2011-12-14 |
| 35167 | SUPPL | 2011-12-14 |
| 25564 | SUPPL | 2011-12-14 |
| 13241 | SUPPL | 2011-12-14 |
| 3123 | SUPPL | 2011-12-14 |
| 3122 | SUPPL | 2011-12-14 |
| 41580 | SUPPL | 2007-11-19 |
| 13240 | SUPPL | 2005-03-29 |
| 3121 | SUPPL | 2005-03-29 |
| 25563 | SUPPL | 2003-11-26 |
| 3120 | SUPPL | 2003-09-29 |
| 41579 | ORIG | 2003-08-08 |
| 3119 | SUPPL | 2001-04-23 |
| 25562 | SUPPL | 2001-04-11 |